In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts

Abstract Background Considering the need for new anti-malarial drugs, further investigations on Keetia leucantha (Rubiaceae), an in vitro antiplasmodial plant traditionally used to treat malaria, were carried out. This paper aimed to assess the in vivo anti-malarial efficacy of K. leucantha triterpe...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Claire Beaufay, Marie-France Hérent, Joëlle Quetin-Leclercq, Joanne Bero
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2017
Subjects:
Online Access:https://doi.org/10.1186/s12936-017-2054-y
https://doaj.org/article/f2ecd2257ef345eebd85479e212d973c
id ftdoajarticles:oai:doaj.org/article:f2ecd2257ef345eebd85479e212d973c
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:f2ecd2257ef345eebd85479e212d973c 2023-05-15T15:13:15+02:00 In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts Claire Beaufay Marie-France Hérent Joëlle Quetin-Leclercq Joanne Bero 2017-10-01T00:00:00Z https://doi.org/10.1186/s12936-017-2054-y https://doaj.org/article/f2ecd2257ef345eebd85479e212d973c EN eng BMC http://link.springer.com/article/10.1186/s12936-017-2054-y https://doaj.org/toc/1475-2875 doi:10.1186/s12936-017-2054-y 1475-2875 https://doaj.org/article/f2ecd2257ef345eebd85479e212d973c Malaria Journal, Vol 16, Iss 1, Pp 1-8 (2017) Keetia leucantha Triterpene esters Anti-malarial Plasmodium Oleanolic Ursolic Arctic medicine. Tropical medicine RC955-962 Infectious and parasitic diseases RC109-216 article 2017 ftdoajarticles https://doi.org/10.1186/s12936-017-2054-y 2022-12-31T15:55:58Z Abstract Background Considering the need for new anti-malarial drugs, further investigations on Keetia leucantha (Rubiaceae), an in vitro antiplasmodial plant traditionally used to treat malaria, were carried out. This paper aimed to assess the in vivo anti-malarial efficacy of K. leucantha triterpenic esters previously identified as the most in vitro active components against Plasmodium falciparum and their potential toxicity as well as those of anti-malarial extracts. Results These eight triterpenic esters and the major antiplasmodial triterpenic acids, ursolic and oleanolic acids, were quantified in the twigs dichloromethane extract by validated HPLC–UV methods. They account for about 19% of this extract (16.9% for acids and 1.8% for esters). These compounds were also identified in trace in the twigs decoction by HPLC-HRMS. Results also showed that extracts and esters did not produce any haemolysis, and were devoid of any acute toxicity at a total cumulative dose of 800 and 150 mg/kg respectively. Moreover, esters given intraperitoneally at 50 mg/kg/day to Plasmodium berghei-infected mice showed a very significant (p < 0.01) parasitaemia inhibition (27.8 ± 5.4%) on day 4 post-infection compared to vehicle-treated mice. Conclusions These results bring out new information on the safety of K. leucantha use and on the identification of anti-malarial compounds from its dichloromethane extract. Its activity can be explained by the presence of triterpenic acids and esters which in vivo activity and safety were demonstrated for the first time. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Malaria Journal 16 1
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Keetia leucantha
Triterpene esters
Anti-malarial
Plasmodium
Oleanolic
Ursolic
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
spellingShingle Keetia leucantha
Triterpene esters
Anti-malarial
Plasmodium
Oleanolic
Ursolic
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Claire Beaufay
Marie-France Hérent
Joëlle Quetin-Leclercq
Joanne Bero
In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts
topic_facet Keetia leucantha
Triterpene esters
Anti-malarial
Plasmodium
Oleanolic
Ursolic
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
description Abstract Background Considering the need for new anti-malarial drugs, further investigations on Keetia leucantha (Rubiaceae), an in vitro antiplasmodial plant traditionally used to treat malaria, were carried out. This paper aimed to assess the in vivo anti-malarial efficacy of K. leucantha triterpenic esters previously identified as the most in vitro active components against Plasmodium falciparum and their potential toxicity as well as those of anti-malarial extracts. Results These eight triterpenic esters and the major antiplasmodial triterpenic acids, ursolic and oleanolic acids, were quantified in the twigs dichloromethane extract by validated HPLC–UV methods. They account for about 19% of this extract (16.9% for acids and 1.8% for esters). These compounds were also identified in trace in the twigs decoction by HPLC-HRMS. Results also showed that extracts and esters did not produce any haemolysis, and were devoid of any acute toxicity at a total cumulative dose of 800 and 150 mg/kg respectively. Moreover, esters given intraperitoneally at 50 mg/kg/day to Plasmodium berghei-infected mice showed a very significant (p < 0.01) parasitaemia inhibition (27.8 ± 5.4%) on day 4 post-infection compared to vehicle-treated mice. Conclusions These results bring out new information on the safety of K. leucantha use and on the identification of anti-malarial compounds from its dichloromethane extract. Its activity can be explained by the presence of triterpenic acids and esters which in vivo activity and safety were demonstrated for the first time.
format Article in Journal/Newspaper
author Claire Beaufay
Marie-France Hérent
Joëlle Quetin-Leclercq
Joanne Bero
author_facet Claire Beaufay
Marie-France Hérent
Joëlle Quetin-Leclercq
Joanne Bero
author_sort Claire Beaufay
title In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts
title_short In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts
title_full In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts
title_fullStr In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts
title_full_unstemmed In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts
title_sort in vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form keetia leucantha and crude extracts
publisher BMC
publishDate 2017
url https://doi.org/10.1186/s12936-017-2054-y
https://doaj.org/article/f2ecd2257ef345eebd85479e212d973c
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Malaria Journal, Vol 16, Iss 1, Pp 1-8 (2017)
op_relation http://link.springer.com/article/10.1186/s12936-017-2054-y
https://doaj.org/toc/1475-2875
doi:10.1186/s12936-017-2054-y
1475-2875
https://doaj.org/article/f2ecd2257ef345eebd85479e212d973c
op_doi https://doi.org/10.1186/s12936-017-2054-y
container_title Malaria Journal
container_volume 16
container_issue 1
_version_ 1766343834673872896